Ruyi Xue Selected Research

Ruyi Xue Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 10/2009
10	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 02/2018 - 01/2009
2	Thrombosis (Thrombus) 04/2021 - 03/2015
2	Non-alcoholic Fatty Liver Disease 07/2014 - 05/2014
2	Chronic Hepatitis B 07/2011 - 01/2011
1	Colitis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Genomic Instability 01/2021
1	Cholangiocarcinoma 05/2020
1	Acute Coronary Syndrome 01/2020
1	Lymphoma (Lymphomas) 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2018
1	Cholestasis 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Inflammation (Inflammations) 03/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Esophageal Squamous Cell Carcinoma 08/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014
1	Fatty Liver 07/2014
1	Alcoholic Fatty Liver 05/2014
1	Carcinogenesis 03/2013
1	Prostatic Neoplasms (Prostate Cancer) 08/2011
1	Stomach Neoplasms (Stomach Cancer) 02/2010
1	Fibrosis (Cirrhosis) 01/2009
1	Liver Neoplasms (Liver Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2013 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
3	Biological ProductsIBA 11/2018 - 03/2015
2	NLR ProteinsIBA 01/2020 - 03/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 05/2014
1	Immune Checkpoint InhibitorsIBA 01/2022
1	tricyclodecane-9-yl-xanthogenateIBA 04/2021
1	InflammasomesIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Lamin Type A (Lamin A)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 05/2020
1	LigandsIBA 05/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 12/2018
1	Gemcitabine FDA Link 12/2018
1	venetoclaxIBA 12/2018
1	PolyaminesIBA 11/2018
1	EnzymesIBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Polyamine OxidaseIBA 11/2018
1	Connective Tissue Growth FactorIBA 02/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	estrone sulfotransferaseIBA 01/2018
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 04/2016
1	NucleotidesIBA 03/2015
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 03/2015
1	Inhibitor of Apoptosis ProteinsIBA 03/2015
1	Sorafenib (BAY 43-9006)FDA Link 03/2015
1	Docetaxel (Taxotere)FDA Link 08/2014
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	Cytochromes c (Cytochrome c)IBA 08/2014
1	Caspase 8 (Caspase-8)IBA 08/2014
1	Caspase 9IBA 08/2014
1	FructoseIBA 07/2014
1	LipopolysaccharidesIBA 07/2014
1	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2014
1	Toll-Like Receptor 2IBA 06/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013
1	Sarcosine (Methylglycine)IBA 08/2011
1	Peptides (Polypeptides)IBA 07/2011
1	Biotin (Vitamin H)FDA Link 01/2011
1	CytokinesIBA 01/2011
1	4-sulfophenylmethallyl ether (SPME)IBA 04/2008
1	n-hexanal (hexanal)IBA 04/2008
1	octaneIBA 04/2008
1	1-octen-3-olIBA 04/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2015
1	Immunotherapy 01/2022
1	Percutaneous Coronary Intervention 01/2020
1	Drug Therapy (Chemotherapy) 08/2014
1	Lasers (Laser) 07/2011